Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GBS Vaccine in HIV Positive and Negative Pregnant Women
NCT01412801Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of group b streptococcus trivalent vaccine in group B streptococcal infection, sponsored by Novartis. Started Sep 2011; status: completed.
02
Drugs
group b streptococcus trivalent vaccine
03
Conditions
group B streptococcal infection
Beyond the preview
Go deeper on NCT01412801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412801.